Proc Natl Acad Sci USA 2006, 103:2257–2261.PubMedCrossRef Selleck PRN1371 7. Yan H, Wu J, Liu W, Zuo Y, Chen S, Zhang S, Zeng M, Huang W: MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells. Hum Gene

Ther 2010, 21:1723–1734.PubMedCrossRef 8. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DLW, Au GKH: MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299:425.PubMedCrossRef 9. Malzkorn B, Wolter M, Liesenberg F, Grzendowski M, Stühler K, Meyer HE, Reifenberger G: Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathol 2010, 20:539–550.PubMedCrossRef 10. Savolitinib Trompeter HI, Abbad H, Iwaniuk KM, Hafner M, Renwick N, Tuschl T, Schira J, Müller HW, Wernet P: MicroRNAs MiR-17, MiR-20a, and MiR-106b act in concert to modulate E2F activity on cell cycle arrest during neuronal lineage differentiation of USSC. PLoS One 2011, 6:e16138.PubMedCrossRef 11. Han ZB ZL, Teng MJ, Fan JW, Tang HM, Wu JY, Chen HY WZW, Qiu GQ,

Peng ZH: Identification of recurrence related microRNAs in hepatocellular carcinoma following liver transplantation.pdf. Mol Oncol 2012, 6:445–457.PubMedCrossRef 12. Akgul C: Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci 2009, 66:1326–1336.PubMedCrossRef 13. Fleischer B, Schulze-Bergkamen H, Schuchmann M, Weber A, Biesterfeld S, Müller M, Krammer PH, Galle PR: Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. Int J Oncol 2006, 28:25.PubMed 14. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie

S, Schwartz ME, Grazi GL: Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: Smoothened a retrospective, exploratory analysis. Lancet Oncol 2009, 10:35–43.PubMedCrossRef 15. Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, Liang TB, Wu LM: Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008, 85:1726.PubMedCrossRef 16. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR: Real-time quantification of microRNAs by stem–loop RT–PCR. Nucleic Acids Res 2005, 33:e179.PubMedCrossRef 17. Anglicheau D, Sharma VK, Ding R, Hummel A, Snopkowski C, Dadhania D, Seshan SV, Suthanthiran M: MicroRNA expression profiles predictive of human renal allograft status. Proc Natl Acad Sci 2009, 106:5330.PubMedCrossRef 18. Maddika S, Ande SR, selleck products Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M: Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 2007, 10:13–29.PubMedCrossRef 19.